The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Epidemiology of non-alcoholic fatty liver disease in China
Open accessAbstract
Fatty liver (steatosis) is highly prevalent in China and is more often linked to obesity than to alcoholism. Among more affluent regions of China, the community prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 15%. With the increasing pandemic of obesity, the prevalence of NAFLD has approximately doubled in the past decade. The risk factors resemble those in other ethnic populations, but it is important to note that ethnic-specific definitions of central obesity, obesity and metabolic syndrome are more useful in assessment of Chinese people. The full range of histological manifestations of NAFLD has been demonstrated in Chinese patients, but to date hepatic severity is generally mild. In contrast to chronic hepatitis C, steatosis is less common in patients with chronic hepatitis B; it is associated with metabolic, and not viral factors and does not appear to affect disease severity. Although long-term outcomes of NAFLD in Chinese populations remain unclear, it may be a predictor of metabolic disorders, diabetes and cardiovascular disease. Public health interventions are therefore indicated to halt or reverse the national trend of obesity in China so as to improve liver as well as metabolic health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Self-citationNonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Self-citationDeurenberg, P., Deurenberg‐Yap, M., & Guricci, S. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00065.x · Cited by 1,326
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Self-citationPrevalence of the metabolic syndrome and overweight among adults in China
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66375-1 · Cited by 917 · cited 4×
“5%) have type 2 diabetes mellitus (T2DM), and 160 million (12%) have high blood pressure [4,5].”
BackgroundInfluentialGlobal challenges in liver disease
Williams, R. (2006) · Hepatology · doi:10.1002/hep.21347 · Cited by 788
Farrell, G. C., Chitturi, S., Lau, G. K., Sollano, J. D., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05002.x · Cited by 517
Self-citationOverweight and obesity in China
Wu, Y. (2006) · BMJ · doi:10.1136/bmj.333.7564.362 · Cited by 454
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
Fan, J.-G., Zhu, J., Li, X.-J., Chen, L., Li, L., Dai, F., Li, F., & Chen, S.-Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.042 · Cited by 404
Self-citationAmarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395
GI Epidemiology: nonalcoholic fatty liver disease
ANGULO, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 369
Alcohol Consumption and the Prevalence of the Metabolic Syndrome in the U.S.
Freiberg, M. S., Cabral, H. J., Heeren, T. C., Vasan, R. S., & Curtis Ellison, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2954 · Cited by 319
Chen, C.-H., Huang, M.-H., Yang, J.-C., Nien, C.-K., Yang, C.-C., Yeh, Y.-H., & Yueh, S.-K. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00016 · Cited by 294
What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?
Fan, J., Saibara, T., Chitturi, S., Kim, B. I., Sung, J. J. Y., Chutaputti, A., & NAFLD, T. A. W. P. F. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04952.x · Cited by 267
Self-citationPrevalence of fatty liver disease and its risk factors in the population of South China
Zhou, Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.13.6419 · Cited by 246
Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases*
ZENG, M. D., FAN, J. G., LU, L. G., LI, Y. M., CHEN, C. W., WANG, B. Y., & MAO, Y. M. (2008) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2008.00331.x · Cited by 242
Self-citationLiu, J., & Fan, D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60723-5 · Cited by 227
Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver Disease
Wong, V. W., Hui, A. Y., Tsang, S. W., Chan, J. L., Tse, A. M., Chan, K., So, W., Cheng, A. Y., Ng, W., Wong, G. L., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.011 · Cited by 200
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders
Fan, J., Li, F., Cai, X., Peng, Y., Ao, Q., & Gao, Y. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04781.x · Cited by 193
Self-citationUltrasonographical Diagnosis of Fatty Liver: Significance of the Liver-Kidney Contrast
YAJIMA, Y., OHTA, K., NARUI, T., ABE, R., SUZUKI, H., & OHTSUKI, M. (1983) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.139.43 · Cited by 189
Fatty liver and the metabolic syndrome among Shanghai adults
FAN, J., ZHU, J., LI, X., CHEN, L., LU, Y., LI, L., DAI, F., LI, F., & CHEN, S. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04058.x · Cited by 186
Self-citationShen, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i5.1106 · Cited by 170
[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].
(2006) · PubMed · Cited by 167
(2004) · Wiley eBooks · doi:10.1002/9780470987438 · Cited by 156
Chen, C., Huang, M., Yang, J., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04615.x · Cited by 140
Jan, C.-F., Chen, C.-J., Chiu, Y.-H., Chen, L.-S., Wu, H.-M., Huang, C.-C., Yen, M.-F., & Chen, T. H.-H. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803204 · Cited by 132
Shi, J., Fan, J., Wu, R. J., Gao, X., Zhang, L. R., Wang, H., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05531.x · Cited by 124
Self-citationWong, V. W., Hui, A., Tsang, S. W., Chan, J. L.-Y., Wong, G. L., Chan, A. W. H., So, W., CHENG, A. Y. S., Tong, P. C. Y., Chan, F. K. L., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03112.x · Cited by 96
Histological progression of non‐alcoholic fatty liver disease in Chinese patients
Hui, A., Wong, V. W., Chan, H. L., Liew, C. T., Chan, J. L.-Y., Chan, F. K. L., & Sung, J. J. �. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02334.x · Cited by 96
Metabolic correlates of nonalcoholic fatty liver in women and men
Vega, G. L., Chandalia, M., Szczepaniak, L. S., & Grundy, S. M. (2007) · Hepatology · doi:10.1002/hep.21727 · Cited by 91
Hsing, A. W., Zhang, M.-D., Rashid, A., McGlynn, K. A., Wang, B., Niwa, S., Ortiz‐Conde, B. A., Goedert, J. J., Fraumeni, J. F., OʼBrien, T. R., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23251 · Cited by 86
Hui, Y., Li, Y., Yu‐Qiang, N., Wei‐Hong, S., Du, Y., Xiao-bo, L., & Yong-jian, Z. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01623.x · Cited by 77
Fatty Liver Disease NASH and Related Disorders
Hughes, R. D. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200606000-00020 · Cited by 71
Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies.
Fan, J., & Peng, Y. (2007) · PubMed · Cited by 67
Self-citationWong, V. W., Wong, G. L., Tsang, S. W., Hui, A., Chan, A. W. H., Choi, P. C., So, W., Tse, A. M. L., Chan, F. K. L., Sung, J. J. �., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05344.x · Cited by 66
Mesenteric fat thickness as an independent determinant of fatty liver
Liu, K. H., Chan, Y. L., Chan, J. C. N., Chan, J. C. N., & Kong, W. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803201 · Cited by 61
Hepatic Histopathology of Morbid Obesity: Concurrence of Other Forms of Chronic Liver Disease
Liew, P., Lee, W., Lee, Y.-C., Wang, H.-H., Wang, W., & Lin, Y.-C. (2006) · Obesity Surgery · doi:10.1381/096089206779319392 · Cited by 60
Bjornsson, E. S., & Angulo, P. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.09.001 · Cited by 56
Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health
Chitturi, S., & Farrell, G. C. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04995.x · Cited by 54
Self-citationMetabolic Syndrome Is Related to Nonalcoholic Steatohepatitis in Severely Obese Subjects
Huang, H., Lin, W., Lee, L., Wang, H.-H., Lee, W., & Huang, K. (2007) · Obesity Surgery · doi:10.1007/s11695-008-9423-0 · Cited by 49
Fan, J., Li, F., Cai, X., Peng, Y., Ao, Q., & Gao, Y. T. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04892.x · Cited by 46
Self-citationImpact of non‐alcoholic fatty liver disease on accelerated metabolic complications
Fan, J. (2008) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2008.00323.x · Cited by 45
Self-citationAssociation of metabolic syndrome and hepatitis B infection in a Chinese population
Luo, B., Wang, Y., & Wang, K. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.012 · Cited by 45
Wu, Y. J., Chen, L. S., & Qiang, W. G. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01219.x · Cited by 45
Fueki, Y., Miida, T., Wardaningsih, E., Ito, M., Nakamura, A., Takahashi, A., Hanyu, O., Tsuda, A., Saitō, H., Hama, H., et al. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.03.027 · Cited by 44
VAT fat is bad for the liver, SAT fat is not!
Fan, J., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05474.x · Cited by 39
Self-citationFan, J., Cai, X.-B., Li, L., Li, X., Dai, F., & Zhu, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2418 · Cited by 36
Self-citationEtiologies of chronic liver diseases in Hong Kong
Fung, K. T.-T., Fung, J., Lai, C., & Yuen, M. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3281ace0b7 · Cited by 32
[Diagnostic criteria of nonalcoholic fatty liver disease].
(2003) · PubMed · Cited by 32
Wang, Z., Xia, B., Ma, C., Hu, Z., Chen, X., & Cao, P. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.052258 · Cited by 29
Primary biliary cirrhosis in Asians: Less common than in Europeans, but just as depressing
Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05379.x · Cited by 19
Self-citationPractical Approach to the Diagnosis and Management of People With Fatty Liver Diseases
George, J., & Farrell, G. C. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch15 · Cited by 13
Self-citationObesity, Fatty Liver and Liver Cancer
Yu, J. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-8684-7 · Cited by 8
Nonalcoholic Fatty Liver Disease Manifesting Esophageal Variceal Bleeding
Tang, C.-P., Huang, Y., Tsay, S., Chang, F., & Lee, S. (2006) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70201-1 · Cited by 6
Cited by
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
New trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S.-U., & Wong, V. W.-S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,083
Self-citationSayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.001 · Cited by 529
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Sarin, S. K., Kumar, M., Eslam, M., George, J., Al Mahtab, M., Akbar, S. M. F., Jia, J., Tian, Q., Aggarwal, R., Muljono, D. H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30342-5 · Cited by 525
NAFLD in Asia—as common and important as in the West
Farrell, G. C., Wong, V. W.-S., & Chitturi, S. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.34 · Cited by 432
Self-citation
Metadata
- Authors
- Fan, J.-G., & Farrell, G. C.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 50
- Issue
- 1
- Pages
- 204-210
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2034527070
- Cited by
- 502
- References
- 54
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.